BICX
BioCorRx Inc.
Price Chart
Latest Quote
$0.38
+0.00 (+0.00%)
Current Price
| Previous Close | $0.38 |
| Open | $0.40 |
| Day High | $0.40 |
| Day Low | $0.40 |
| Volume | 3,048 |
Stock Information
| Shares Outstanding | 29.06M |
| Total Debt | $2.16M |
| Cash Equivalents | $212K |
| Revenue | $877K |
| Net Income | $-3.43M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $10.98M |
| EPS (TTM) | $-0.16 |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $12.76M |
| Sales | $877K |
| Income | $-3.43M |
| Book/sh | $-0.40 |
| Cash/sh | $0.01 |
Financial Ratios
| Quick Ratio | 0.08 |
| Current Ratio | 0.12 |
Returns & Margins
| ROA | -66.34% |
| Gross Margin | 94.64% |
| Operating Margin | -442.64% |
Ownership
| Insider Ownership | 61.36% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -5.40 |
| P/S | 12.53 |
| P/B | -0.95 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.38 |
| SMA50 | $0.37 |
| SMA200 | $0.36 |
| RSI | 44.82 |
| ATR | 0.0821 |
| Shares Float | 18.74M |
| Volatility | 0.17 |
Performance History
| Week | -0.26% |
| Month | +55.56% |
| Quarter | +48.24% |
| 6 Months | +14.55% |
| YTD | +29.90% |
| Year | +5.00% |
| 3 Years | -78.86% |
| 5 Years | -91.60% |
| 10 Years | -81.10% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.38 | 0 |
| 2026-06-03 | $0.38 | 0 |
| 2026-06-02 | $0.38 | 200 |
| 2026-06-01 | $0.33 | 200 |
| 2026-05-29 | $0.35 | 600 |
| 2026-05-28 | $0.38 | 0 |
| 2026-05-27 | $0.38 | 0 |
| 2026-05-26 | $0.38 | 100 |
| 2026-05-22 | $0.40 | 0 |
| 2026-05-21 | $0.40 | 0 |
| 2026-05-20 | $0.40 | 4,000 |
| 2026-05-19 | $0.44 | 20,000 |
| 2026-05-18 | $0.50 | 0 |
| 2026-05-15 | $0.50 | 27,800 |
| 2026-05-14 | $0.41 | 0 |
| 2026-05-13 | $0.41 | 200 |
| 2026-05-12 | $0.34 | 1,000 |
| 2026-05-11 | $0.31 | 0 |
| 2026-05-08 | $0.31 | 0 |
| 2026-05-07 | $0.31 | 0 |
| 2026-05-06 | $0.31 | 1,800 |
| 2026-05-05 | $0.24 | 0 |
About BioCorRx Inc.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss management program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on BICX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,667 | $35,986 | $15,279 | $5,881 |
| Cost Of Revenue | $1,667 | $35,986 | $15,279 | $5,881 |
| Total Revenue | $7,665 | $89,160 | $213,841 | $48,272 |
| Operating Revenue | $7,665 | $89,160 | $213,841 | $48,272 |
| Expenses | ||||
| Interest Expense | $1,527,553 | $886,627 | $1,086,775 | $565,684 |
| Total Expenses | $3,656,894 | $2,895,980 | $3,122,340 | $4,580,975 |
| Other Income Expense | $-35,320 | $-77,043 | $-381,558 | $-112,251 |
| Other Non Operating Income Expenses | $129,282 | $5,275 | $-182,619 | $29,229 |
| Net Non Operating Interest Income Expense | $-1,527,553 | $-886,627 | $-1,086,775 | $-565,684 |
| Interest Expense Non Operating | $1,527,553 | $886,627 | $1,086,775 | $565,684 |
| Operating Expense | $3,655,227 | $2,859,994 | $3,107,061 | $4,575,094 |
| Other Operating Expenses | $-1,473,276 | $-932,996 | $-1,789,496 | $-835,924 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-5,106,124 | $-3,766,913 | $-4,369,413 | $-5,208,254 |
| Net Interest Income | $-1,527,553 | $-886,627 | $-1,086,775 | $-565,684 |
| Normalized Income | $-4,941,522 | $-3,684,595 | $-4,170,474 | $-5,066,774 |
| Net Income From Continuing And Discontinued Operation | $-5,106,124 | $-3,766,913 | $-4,369,413 | $-5,208,254 |
| Total Operating Income As Reported | $-5,122,505 | $-3,787,796 | $-4,697,995 | $-5,510,107 |
| Net Income Common Stockholders | $-5,106,124 | $-3,766,913 | $-4,369,413 | $-5,278,381 |
| Net Income | $-5,106,124 | $-3,766,913 | $-4,369,413 | $-5,208,254 |
| Net Income Including Noncontrolling Interests | $-5,212,102 | $-3,770,490 | $-4,376,832 | $-5,210,638 |
| Net Income Continuous Operations | $-5,212,102 | $-3,770,490 | $-4,376,832 | $-5,210,638 |
| Pretax Income | $-5,212,102 | $-3,770,490 | $-4,376,832 | $-5,210,638 |
| Special Income Charges | $-164,602 | $-82,318 | $-198,939 | $-141,480 |
| Operating Income | $-3,649,229 | $-2,806,820 | $-2,908,499 | $-4,532,703 |
| Depreciation Amortization Depletion Income Statement | $33,145 | $26,808 | $27,450 | $64,328 |
| Depreciation And Amortization In Income Statement | $33,145 | $26,808 | $27,450 | $64,328 |
| Gross Profit | $5,998 | $53,174 | $198,562 | $42,391 |
| Per Share | ||||
| Diluted EPS | $-0.49 | $-0.45 | $-0.61 | $-0.81 |
| Basic EPS | $-0.49 | $-0.45 | $-0.61 | $-0.81 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,424,698 | $-2,601,609 | $-2,949,153 | $-4,334,531 |
| Total Unusual Items | $-164,602 | $-82,318 | $-198,939 | $-141,480 |
| Total Unusual Items Excluding Goodwill | $-164,602 | $-82,318 | $-198,939 | $-141,480 |
| Reconciled Depreciation | $95,249 | $199,936 | $141,965 | $168,943 |
| EBITDA (Bullshit earnings) | $-3,589,300 | $-2,683,927 | $-3,148,092 | $-4,476,011 |
| EBIT | $-3,684,549 | $-2,883,863 | $-3,290,057 | $-4,644,954 |
| Diluted Average Shares | $10,464,373 | $8,344,079 | $7,198,312 | $6,491,067 |
| Basic Average Shares | $10,464,373 | $8,344,079 | $7,198,312 | $6,491,067 |
| Diluted NI Availto Com Stockholders | $-5,106,124 | $-3,766,913 | $-4,369,413 | $-5,278,381 |
| Minority Interests | $105,978 | $3,577 | $7,419 | $2,384 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Other Special Charges | $164,602 | $34,338 | $198,939 | - |
| Impairment Of Capital Assets | $0 | $47,980 | $0 | $141,480 |
| Research And Development | $1,482,877 | $891,063 | $1,459,458 | $1,605,907 |
| Selling General And Administration | $3,612,481 | $2,875,119 | $3,409,649 | $3,740,783 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $70,127 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-12,128,268 | $-9,832,717 | $-8,134,660 | $-6,903,003 |
| Total Assets | $385,941 | $388,887 | $766,594 | $819,975 |
| Total Non Current Assets | $267,945 | $201,768 | $449,684 | $591,649 |
| Non Current Prepaid Assets | $41,936 | $44,520 | $44,520 | $44,520 |
| Goodwill And Other Intangible Assets | $7,848 | $9,027 | $58,186 | $59,365 |
| Other Intangible Assets | $7,848 | $9,027 | $58,186 | $59,365 |
| Current Assets | $117,996 | $187,119 | $316,910 | $228,326 |
| Prepaid Assets | $29,963 | $44,891 | $82,765 | $84,629 |
| Receivables | $0 | $77,006 | $165,530 | $57,859 |
| Accounts Receivable | $0 | $740 | $35,378 | $1,500 |
| Cash Cash Equivalents And Short Term Investments | $88,033 | $65,222 | $68,615 | $85,838 |
| Cash And Cash Equivalents | $88,033 | $65,222 | $68,615 | $85,838 |
| Cash Financial | $88,033 | $65,222 | $68,615 | $85,838 |
| Other Receivables | - | $76,266 | $130,152 | $56,359 |
| Allowance For Doubtful Accounts Receivable | - | - | $0 | $0 |
| Gross Accounts Receivable | - | - | $35,378 | $1,500 |
| Debt | ||||
| Net Debt | $2,519,133 | $1,613,082 | $1,293,474 | $1,131,492 |
| Total Debt | $2,806,350 | $1,811,981 | $1,677,760 | $1,652,735 |
| Long Term Debt And Capital Lease Obligation | $230,156 | $83,411 | $255,178 | $489,832 |
| Long Term Debt | $71,029 | $72,466 | $73,850 | $174,160 |
| Current Debt And Capital Lease Obligation | $2,576,194 | $1,728,570 | $1,422,582 | $1,162,903 |
| Current Debt | $2,536,137 | $1,605,838 | $1,288,239 | $1,043,170 |
| Other Current Borrowings | - | - | - | $31,580 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,741,173 | $10,341,411 | $8,968,325 | $7,781,451 |
| Total Non Current Liabilities Net Minority Interest | $4,533,558 | $3,910,202 | $3,604,533 | $3,395,007 |
| Other Non Current Liabilities | $4,303,402 | $3,822,746 | $3,345,310 | $2,867,874 |
| Non Current Deferred Liabilities | $0 | $4,045 | $4,045 | $37,301 |
| Current Liabilities | $8,207,615 | $6,431,209 | $5,363,792 | $4,386,444 |
| Current Deferred Liabilities | $71,314 | $0 | $33,256 | $37,542 |
| Current Notes Payable | $2,536,137 | $1,605,838 | $1,288,239 | $1,011,590 |
| Payables And Accrued Expenses | $5,560,107 | $4,605,858 | $3,907,954 | $3,185,999 |
| Interest Payable | $1,954,226 | $1,752,859 | $1,545,180 | $1,383,424 |
| Payables | $3,023,517 | $2,473,457 | $2,013,250 | $1,776,905 |
| Accounts Payable | $3,023,517 | $2,473,457 | $2,013,250 | $1,776,905 |
| Other Current Liabilities | - | $53,460 | - | - |
| Equity | ||||
| Common Stock Equity | $-12,142,036 | $-9,845,306 | $-8,098,090 | $-6,865,254 |
| Preferred Stock Equity | $21,616 | $21,616 | $21,616 | $21,616 |
| Total Equity Gross Minority Interest | $-12,355,232 | $-9,952,524 | $-8,201,731 | $-6,961,476 |
| Stockholders Equity | $-12,120,420 | $-9,823,690 | $-8,076,474 | $-6,843,638 |
| Other Equity Interest | $100,000 | $100,009 | $100,000 | $100,000 |
| Retained Earnings | $-83,209,142 | $-78,103,018 | $-74,336,105 | $-69,966,692 |
| Other | ||||
| Ordinary Shares Number | $13,299,349 | $8,674,029 | $7,718,636 | $6,698,968 |
| Share Issued | $13,299,349 | $8,674,029 | $7,718,636 | $6,698,968 |
| Tangible Book Value | $-12,149,884 | $-9,854,333 | $-8,156,276 | $-6,924,619 |
| Invested Capital | $-9,534,870 | $-8,167,002 | $-6,736,001 | $-5,647,924 |
| Working Capital | $-8,089,619 | $-6,244,090 | $-5,046,882 | $-4,158,118 |
| Capital Lease Obligations | $199,184 | $133,677 | $315,671 | $435,405 |
| Total Capitalization | $-12,049,391 | $-9,751,224 | $-8,002,624 | $-6,669,478 |
| Minority Interest | $-234,812 | $-128,834 | $-125,257 | $-117,838 |
| Additional Paid In Capital | $70,953,807 | $68,149,029 | $66,130,296 | $62,994,739 |
| Capital Stock | $34,915 | $30,290 | $29,335 | $28,315 |
| Common Stock | $13,299 | $8,674 | $7,719 | $6,699 |
| Preferred Stock | $21,616 | $21,616 | $21,616 | $21,616 |
| Non Current Deferred Revenue | $0 | $4,045 | $4,045 | $37,301 |
| Long Term Capital Lease Obligation | $159,127 | $10,945 | $181,328 | $315,672 |
| Current Deferred Revenue | $56,590 | $0 | $33,256 | $34,981 |
| Current Capital Lease Obligation | $40,057 | $122,732 | $134,343 | $119,733 |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $43,321 | $0 | - |
| Current Accrued Expenses | $2,536,590 | $2,132,401 | $1,894,704 | $1,409,094 |
| Net PPE | $218,161 | $148,221 | $346,978 | $487,764 |
| Accumulated Depreciation | $-175,574 | $-143,608 | $-117,979 | $-91,708 |
| Gross PPE | $393,735 | $291,829 | $464,957 | $579,472 |
| Leases | $42,288 | $42,288 | $42,288 | $42,288 |
| Other Properties | $101,200 | $101,200 | $101,200 | $101,200 |
| Machinery Furniture Equipment | $51,063 | $51,063 | $51,063 | $51,063 |
| Buildings And Improvements | $199,184 | $97,278 | $270,406 | $384,921 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,096,254 | $-1,853,282 | $-2,041,773 | $-3,587,655 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,096,254 | $-1,853,282 | $-2,041,773 | $-3,537,658 |
| Cash Flow From Continuing Operating Activities | $-1,096,254 | $-1,853,282 | $-2,041,773 | $-3,537,658 |
| Operating Gains Losses | $164,602 | $34,338 | $65,515 | $-28,229 |
| Investing Activities | ||||
| Investing Cash Flow | - | - | $0 | $-49,997 |
| Cash Flow From Continuing Investing Activities | - | - | $0 | $-49,997 |
| Capital Expenditure | - | - | - | $-49,997 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $915,000 | $1,250,000 | $2,250,000 |
| Financing Cash Flow | $1,119,065 | $1,849,889 | $2,024,550 | $3,081,440 |
| Cash Flow From Continuing Financing Activities | $1,119,065 | $1,849,889 | $2,024,550 | $3,081,440 |
| Net Common Stock Issuance | $0 | $915,000 | $1,250,000 | $2,250,000 |
| Common Stock Issuance | $0 | $915,000 | $1,250,000 | $2,250,000 |
| Other | ||||
| Repayment Of Debt | $-12,437 | $-36,384 | $-450 | $0 |
| Issuance Of Debt | $1,131,502 | $971,273 | $775,000 | $831,440 |
| Interest Paid Supplemental Data | $10,731 | $17,188 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $88,033 | $65,222 | $68,615 | $85,838 |
| Beginning Cash Position | $65,222 | $68,615 | $85,838 | $592,053 |
| Changes In Cash | $22,811 | $-3,393 | $-17,223 | $-506,215 |
| Net Issuance Payments Of Debt | $1,119,065 | $934,889 | $774,550 | $831,440 |
| Net Short Term Debt Issuance | $1,120,502 | $936,273 | $775,000 | $700,000 |
| Short Term Debt Payments | $-11,000 | $-35,000 | $0 | - |
| Short Term Debt Issuance | $1,131,502 | $971,273 | $775,000 | $700,000 |
| Net Long Term Debt Issuance | $-1,437 | $-1,384 | $-450 | $131,440 |
| Long Term Debt Payments | $-1,437 | $-1,384 | $-450 | $0 |
| Change In Working Capital | $1,523,125 | $714,265 | $577,549 | $703,835 |
| Change In Other Working Capital | $52,545 | $-33,256 | $-34,981 | $-128,890 |
| Change In Other Current Liabilities | $-66,098 | $-181,994 | $-119,734 | $-106,290 |
| Change In Payables And Accrued Expense | $1,442,160 | $803,117 | $838,071 | $698,631 |
| Change In Prepaid Assets | $17,512 | $37,874 | $1,864 | $72,864 |
| Change In Receivables | $77,006 | $88,524 | $-107,671 | $167,520 |
| Changes In Account Receivables | $740 | $34,638 | $-33,878 | $-1,000 |
| Other Non Cash Items | $1,113,618 | $643,634 | $1,195,521 | $477,436 |
| Stock Based Compensation | $1,219,254 | $277,055 | $354,509 | $209,515 |
| Asset Impairment Charge | $0 | $47,980 | $0 | $141,480 |
| Depreciation Amortization Depletion | $95,249 | $199,936 | $141,965 | $168,943 |
| Depreciation And Amortization | $95,249 | $199,936 | $141,965 | $168,943 |
| Depreciation | $95,249 | $199,936 | $141,965 | $168,943 |
| Net Income From Continuing Operations | $-5,212,102 | $-3,770,490 | $-4,376,832 | $-5,210,638 |
| Long Term Debt Issuance | - | - | $0 | $131,440 |
| Net Intangibles Purchase And Sale | - | - | $0 | $-47,980 |
| Purchase Of Intangibles | - | - | $0 | $-47,980 |
| Net PPE Purchase And Sale | - | - | $0 | $-2,017 |
| Purchase Of PPE | - | - | $0 | $-2,017 |
Fetched: 2026-02-02